Cargando…

Multicolor flow cytometry-based immunophenotyping for preclinical characterization of nanotechnology-based formulations: an insight into structure activity relationship and nanoparticle biocompatibility profiles

INTRODUCTION: Immunophenotyping, which is the identification of immune cell subsets based on antigen expression, is an integral technique used to determine changes of cell composition and activation in various disease states or as a response to different stimuli. As nanoparticles are increasingly ut...

Descripción completa

Detalles Bibliográficos
Autores principales: Newton, Hannah S., Zhang, Jenny, Donohue, Duncan, Unnithan, Ragi, Cedrone, Edward, Xu, Jie, Vermilya, Alison, Malys, Tyler, Clogston, Jeffrey D., Dobrovolskaia, Marina A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10353541/
https://www.ncbi.nlm.nih.gov/pubmed/37470031
http://dx.doi.org/10.3389/falgy.2023.1126012
_version_ 1785074731569905664
author Newton, Hannah S.
Zhang, Jenny
Donohue, Duncan
Unnithan, Ragi
Cedrone, Edward
Xu, Jie
Vermilya, Alison
Malys, Tyler
Clogston, Jeffrey D.
Dobrovolskaia, Marina A.
author_facet Newton, Hannah S.
Zhang, Jenny
Donohue, Duncan
Unnithan, Ragi
Cedrone, Edward
Xu, Jie
Vermilya, Alison
Malys, Tyler
Clogston, Jeffrey D.
Dobrovolskaia, Marina A.
author_sort Newton, Hannah S.
collection PubMed
description INTRODUCTION: Immunophenotyping, which is the identification of immune cell subsets based on antigen expression, is an integral technique used to determine changes of cell composition and activation in various disease states or as a response to different stimuli. As nanoparticles are increasingly utilized for diagnostic and therapeutic applications, it is important to develop methodology that allows for the evaluation of their immunological impact. Therefore, the development of techniques such as immunophenotyping are desirable. Currently, the most common technique used to perform immunophenotyping is multicolor flow cytometry. METHODS: We developed two distinct multicolor flow cytometry immunophenotyping panels which allow for the evaluation of the effects of nanoparticles on the composition and activation status of treated human peripheral blood mononuclear cells. These two panels assess the presence of various lymphoid and myeloid-derived cell populations as well as aspects of their activation statuses—including proliferation, adhesion, co-stimulation/presentation, and early activation—after treatment with controls or nanoparticles. To conduct assay performance qualification and determine the applicability of this method to preclinical characterization of nanoparticles, we used clinical-grade nanoformulations (AmBisome, Doxil and Feraheme) and research-grade PAMAM dendrimers of different sizes (G3, G4 and G5) and surface functionalities (amine-, carboxy- and hydroxy-). RESULTS AND DISCUSSION: We found that formulations possessing intrinsic fluorescent properties (e.g., Doxil and AmBisome) interfere with accurate immunophenotyping; such interference may be partially overcome by dilution. In the absence of interference (e.g., in the case of dendrimers), nanoparticle size and surface functionalities determine their effects on the cells with large amine-terminated dendrimers being the most reactive.
format Online
Article
Text
id pubmed-10353541
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-103535412023-07-19 Multicolor flow cytometry-based immunophenotyping for preclinical characterization of nanotechnology-based formulations: an insight into structure activity relationship and nanoparticle biocompatibility profiles Newton, Hannah S. Zhang, Jenny Donohue, Duncan Unnithan, Ragi Cedrone, Edward Xu, Jie Vermilya, Alison Malys, Tyler Clogston, Jeffrey D. Dobrovolskaia, Marina A. Front Allergy Allergy INTRODUCTION: Immunophenotyping, which is the identification of immune cell subsets based on antigen expression, is an integral technique used to determine changes of cell composition and activation in various disease states or as a response to different stimuli. As nanoparticles are increasingly utilized for diagnostic and therapeutic applications, it is important to develop methodology that allows for the evaluation of their immunological impact. Therefore, the development of techniques such as immunophenotyping are desirable. Currently, the most common technique used to perform immunophenotyping is multicolor flow cytometry. METHODS: We developed two distinct multicolor flow cytometry immunophenotyping panels which allow for the evaluation of the effects of nanoparticles on the composition and activation status of treated human peripheral blood mononuclear cells. These two panels assess the presence of various lymphoid and myeloid-derived cell populations as well as aspects of their activation statuses—including proliferation, adhesion, co-stimulation/presentation, and early activation—after treatment with controls or nanoparticles. To conduct assay performance qualification and determine the applicability of this method to preclinical characterization of nanoparticles, we used clinical-grade nanoformulations (AmBisome, Doxil and Feraheme) and research-grade PAMAM dendrimers of different sizes (G3, G4 and G5) and surface functionalities (amine-, carboxy- and hydroxy-). RESULTS AND DISCUSSION: We found that formulations possessing intrinsic fluorescent properties (e.g., Doxil and AmBisome) interfere with accurate immunophenotyping; such interference may be partially overcome by dilution. In the absence of interference (e.g., in the case of dendrimers), nanoparticle size and surface functionalities determine their effects on the cells with large amine-terminated dendrimers being the most reactive. Frontiers Media S.A. 2023-07-04 /pmc/articles/PMC10353541/ /pubmed/37470031 http://dx.doi.org/10.3389/falgy.2023.1126012 Text en © 2023 Newton, Zhang, Donohue, Unnithan, Cedrone, Xu, Vermilya, Malys, Clogston and Dobrovolskaia. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY) (https://creativecommons.org/licenses/by/4.0/) . The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Allergy
Newton, Hannah S.
Zhang, Jenny
Donohue, Duncan
Unnithan, Ragi
Cedrone, Edward
Xu, Jie
Vermilya, Alison
Malys, Tyler
Clogston, Jeffrey D.
Dobrovolskaia, Marina A.
Multicolor flow cytometry-based immunophenotyping for preclinical characterization of nanotechnology-based formulations: an insight into structure activity relationship and nanoparticle biocompatibility profiles
title Multicolor flow cytometry-based immunophenotyping for preclinical characterization of nanotechnology-based formulations: an insight into structure activity relationship and nanoparticle biocompatibility profiles
title_full Multicolor flow cytometry-based immunophenotyping for preclinical characterization of nanotechnology-based formulations: an insight into structure activity relationship and nanoparticle biocompatibility profiles
title_fullStr Multicolor flow cytometry-based immunophenotyping for preclinical characterization of nanotechnology-based formulations: an insight into structure activity relationship and nanoparticle biocompatibility profiles
title_full_unstemmed Multicolor flow cytometry-based immunophenotyping for preclinical characterization of nanotechnology-based formulations: an insight into structure activity relationship and nanoparticle biocompatibility profiles
title_short Multicolor flow cytometry-based immunophenotyping for preclinical characterization of nanotechnology-based formulations: an insight into structure activity relationship and nanoparticle biocompatibility profiles
title_sort multicolor flow cytometry-based immunophenotyping for preclinical characterization of nanotechnology-based formulations: an insight into structure activity relationship and nanoparticle biocompatibility profiles
topic Allergy
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10353541/
https://www.ncbi.nlm.nih.gov/pubmed/37470031
http://dx.doi.org/10.3389/falgy.2023.1126012
work_keys_str_mv AT newtonhannahs multicolorflowcytometrybasedimmunophenotypingforpreclinicalcharacterizationofnanotechnologybasedformulationsaninsightintostructureactivityrelationshipandnanoparticlebiocompatibilityprofiles
AT zhangjenny multicolorflowcytometrybasedimmunophenotypingforpreclinicalcharacterizationofnanotechnologybasedformulationsaninsightintostructureactivityrelationshipandnanoparticlebiocompatibilityprofiles
AT donohueduncan multicolorflowcytometrybasedimmunophenotypingforpreclinicalcharacterizationofnanotechnologybasedformulationsaninsightintostructureactivityrelationshipandnanoparticlebiocompatibilityprofiles
AT unnithanragi multicolorflowcytometrybasedimmunophenotypingforpreclinicalcharacterizationofnanotechnologybasedformulationsaninsightintostructureactivityrelationshipandnanoparticlebiocompatibilityprofiles
AT cedroneedward multicolorflowcytometrybasedimmunophenotypingforpreclinicalcharacterizationofnanotechnologybasedformulationsaninsightintostructureactivityrelationshipandnanoparticlebiocompatibilityprofiles
AT xujie multicolorflowcytometrybasedimmunophenotypingforpreclinicalcharacterizationofnanotechnologybasedformulationsaninsightintostructureactivityrelationshipandnanoparticlebiocompatibilityprofiles
AT vermilyaalison multicolorflowcytometrybasedimmunophenotypingforpreclinicalcharacterizationofnanotechnologybasedformulationsaninsightintostructureactivityrelationshipandnanoparticlebiocompatibilityprofiles
AT malystyler multicolorflowcytometrybasedimmunophenotypingforpreclinicalcharacterizationofnanotechnologybasedformulationsaninsightintostructureactivityrelationshipandnanoparticlebiocompatibilityprofiles
AT clogstonjeffreyd multicolorflowcytometrybasedimmunophenotypingforpreclinicalcharacterizationofnanotechnologybasedformulationsaninsightintostructureactivityrelationshipandnanoparticlebiocompatibilityprofiles
AT dobrovolskaiamarinaa multicolorflowcytometrybasedimmunophenotypingforpreclinicalcharacterizationofnanotechnologybasedformulationsaninsightintostructureactivityrelationshipandnanoparticlebiocompatibilityprofiles